Skip to main content

Decreased Bleeding with Direct Oral Anticoagulants in Sickle Cell Disease

· One min read
Hants Williams
Hants Williams
Healthcare Informatics Researcher

Abstract​

This study compares bleeding incidents between direct oral anticoagulants and traditional anticoagulation methods in patients with sickle cell disease and venous thromboembolism.

Publication Information​

Published in Acta Haematologica (2019)
DOI: PMID: 31108496

Overview​

The research evaluates the safety and efficacy of direct oral anticoagulants compared to traditional anticoagulation methods in patients with sickle cell disease, focusing on bleeding incidents as a primary outcome.

[Full text available via Acta Haematologica]

Citation​

Patel, A., Williams, H., Baer, M. R., Zimrin, A. B., & Law, J. Y. (2019). Decreased Bleeding Incidence With Direct Oral Anticoagulants Compared to Vitamin K Antagonist and Low-Molecular-Weight Heparin in Patients With Sickle Cell Disease and Venous Thromboembolism. Acta Haematologica, 142(4), 233-238. PMID: 31108496